Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Randomized, Double-blind, Placebo-controlled Parallel-group Clinical Trial to Evaluate the Effects of a Bacillus Coagulans-based Product in Patients With IBS-Diarrhea.

NCT07520422 is registered in ClinicalTrials.gov with Bioagile Therapeutics Pvt. Ltd. as lead sponsor.

NCT NCT07520422
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07520422 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Randomized, Double-blind, Placebo-controlled Parallel-group Clinical Trial to Evaluate the Effects of a Bacillus Coagulans-based Product in Patients With IBS-Diarrhea.
Lead sponsor
Bioagile Therapeutics Pvt. Ltd.
Phase
Not applicable
Overall status
Completed
Start date
February 25, 2023
Completion date
May 25, 2023
Enrollment
50 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ibs-d (diarrhea-predominant)